An interleukin 4 (Ib4)-specific monoclonal antibody (mAb) was administered to mice infected systemically with the yeast Candida albicans, and the animals were monitored for mortality, development of delayed-type hypersensitivity, production of antibodies of different isotypes, release of II.-2, II.-4, Ib6, and interferon 3' (IFN-3') in vitro by splenic CD4 + lymphocytes, and levels of Ib4 and IFN-3' mRNA in these cells. Neutralization of IL-4 by three weekly injections of mAb in several independent experiments resulted in an overall cure rate of 81% versus 0% of controls. Cure was associated with efficient clearance of the yeast from infected organs and histologic evidence of disease resolution, detection of strong T helper type 1 (Thl) responses, and establishment of long-lasting protective immunity. Soon after infection, and as a result of the first or second injection of mAb, there was a decrease in Ib4 mRNA in CD4 + cells, which was accompanied by an increase in the levels of IFN-3'-specific transcripts. Our data thus indicate
ecent evidence indicates that, early after exposure of mice, innate defense mechanisms are the primary means by which proliferation and growth of Candida albicans are held in check in the absence of underlying immunity, whereas later in the course of infection, clearance of the yeast is regulated, at least in part, by T cell-mediated immune responses (1) . Long-term colonization of adult mice in the absence of immunosuppressive and antimicrobial treatment has been achieved by intragastric colonization of infant (2) or germfree (3) mice, or by systemic infection with attenuated yeast cells of variant strains (4, 5) . These studies have demonstrated that both specific cell-mediated immunity (6) (7) (8) and phagocytic cell activity (4, 9, 10) are instrumental in the optimal expression of acquired anti-Candida resistance. In particular, in a systemic C. albicans infection model, evidence has been obtained that preferential production of Thl or Th2 cytokines may underlie the development of protective vs. nonprotective immunity, respectively, as elicited by concomitant chronic infection with attenuated yeast cells (11) .
The role of cytokines in cutaneous lesions of murine leishmaniasis has been demonstrated by experiments in vivo, in which cytokine activities were blocked by administration of anticytokine mAbs. Anti-IFN-3' treatment of genetically resistant mice was found to result in development of progressive Leishmania major infection and detection of Th2 responses (12) . In contrast, anti-IL-4 treatment resuhed in cure of susceptible mice, and the animals demonstrated Thl responses (13, 14) . In general, these data are taken to indicate that IFN-3' and IL-4 are clearly involved in the process of subset differentiation of CD4 + T cells and may exert mutually inhibitory effects on both differentiation and effector functions (14) .
Following our previous observations that anti-IFN-3' treatment in vivo will block the effector functions mediated by endogenous IFN-3" in immunized mice (7) and Th2 cells may be activated and functionally interact with Thl lymphocytes in candidal infections (11), we have investigated the effect of administration of anti-IL-4 mAb on antifungal resistance of systemically infected mice. Anti-IL-4 therapy initiated at the time of infection resulted in cure of a high percentage of mice with establishment of protective immunity. Cure was associated with the detection of Thl responses, including strong delayed-type footpad reactions and low serum IgE. There were also early and remarkable changes in Thl and Th2 cytokine production in vitro by CD4 + cells and cytokine mRNA expression in these cells.
Materials and Methods
Mice. Hybrid (BALB/cCr x DBA/2Cr)F1 (CD2F 0 and inbred BALB/c mice were obtained from Charles giver Breeding Laboratories (Calco, Milan, Italy). Mice of both sexes, ranging in age from 2 to 4 too, were used.
Yeast and Infecn'ons. The origin, characteristics, and growth conditions of the highly pathogenic C. albicans (CA-6) strain used in this study have already been described in detail (6, 7) . For infection, yeast cells were harvested by low-speed centrifugation (1,000 g), washed twice in PBS, and diluted to the desired density to be injected intravenously into mice in a volume of 500 #1. Quantification of yeast cells in organs of infected mice was performed by a plate dilution method, using Sabouraud dextrose agar (6, 7) , and results (means + SEM) were expressed as the number of CFU per organ. For histology, tissues were fixed in formalin, sectioned, and stained with periodic acid-Schi~s reagent or hematoxylin/eosin.
Treatment of Mice with ana'-IL,4 mA ~ The 11Bll hybridoma line, producing rat IgG1 anti-IL-4 mAb (15), was grown as ascites in pristane-primed irradiated BALB/c mice, and the ascites fluid was passed over a desahing column (10DG; Bio-Red Laboratories, Richmond, CA) before antibody purification by means of affinity chromatography with protein A-Sepharose CL-4B (Pharmacia, Uppsala, Sweden). Protein concentration was determined by measuring the OD at 280 nm. Beginning 2 d before infection, mice received 1 mg purified 11Bll mAb in 250 #1 PBS intraperitoneally once per week for 3 wk. Control mice received equivalent amounts of affinity-purified rat IgG1 (Zymed Laboratories, San Francisco, CA).
De/algal-type Hy/xom~t/v/t 7 (/Y/H)' Assa? A direct assay system for measuring the DTH response to call surface antigens was employed (6) in which heat-inactivated CA-6 cells (2 x 106/40 #1 of pyrogen-free saline) were inoculated into the footpads of control or yeast-infected mice. The DTH reaction was recorded 24 h later by weighing the footpad as a measure of swelling, and the results were expressed as the increase in footpad weight (right hind) over that of the saline-injected (left hind) counterpart. Data are the means _+ SEM of six to eight mice per group.
Selection of CD4 + Cells, Production of Culture Supernatants Conmining Cytokine Activity, and Cytokine Assays. CD4 + lymphocytes were positively selected from pools of spleen cells by means of a panning procedure using anti-murine CD4 mAb GK1.5, which resulted in a >95% pure population on FACS | analysis (Becton Dickinson & Co., Mountain View, CA) (6, 7). Supernatants from mixed lymphocyte Candida cultures were obtained by culturing CD4 + lymphocytes in the presence of yeast cells and accessory macrophages (6, 11) . Source and characteristics of the anticytokine antibody reagents used in IFN-% IL-2, IL-4, and Ib6 assays were as described (6, 7, 11) . Briefly, cell supernatants were tested for their concentration of IFN-3, by two-site ELISA using rat anti-murine IFN-3/mAb K4-6A2 as the primary antibody and biotinylated monoclonal AN-18.17.24 as the secondary antibody. Ib2 and IL-4 were measured using the HT2 T lymphocyte line that proliferates in response to either of these cytokines (16) . mAbs $4B6 (antiIb2) and 11Bll (anti-Ib4), at neutralizing concentrations, were used to establish monospecificity. IL-6 activity was determined by its capacity to support the growth of the murine IL-6-dependent cell line 7TD1 (17) . Proliferation was assayed using the tetrazoliumbased colorimetric assay. All cytokine titers were expressed as units per milliliter, calculated by reference to standard curves constructed with known amounts of the recombinant cytokines (Genentech, Inc., South San Francisco, CA).
Antibody Assay. A micro-ELISA procedure was used to quantitate specific antibodies in the sera of yeast-infected mice (11) . The assay involved coating the microtiter plate wells with heat-killed 1 Abbreviation used in this loa~r: DTH, delayed-type hypersensitivity.
CA-6 cells, addition of appropriate dilutions of test antisera (from a pool of two to three mice per group), and a further reaction with alkaline phosphatase--conjugated rabbit anti-mouse IgG, IgG1, IgG2a (Zymed Laboratories), or with biotinylated rat monoclonal anti-mouse IgE (Sanbio by Biological Products, Uden, The Netherlands) followed by an avidin-alkaline phosphatase conjugate (Vector Laboratories, Budingame, CA). After addition of the substrate solution, the OD of triplicate samples was read with an ELISA reader, using a 405-nm filter.
RNA Preparation andPCR. CD4 + lymphocytes, >95% pure, were obtained from spleen cells pooled from two to three animals, and 2 x 107 calls were subjected to KNA extraction by the guanidium thiocyanate-phenol-chloroform procedure (18) . Amplification of synthesized cDNA from each sample was carried out as reported (19) , using 5' sense primers and 3' antisense primers from Clontech Laboratories (Palo Alto, CA). Briefly, 5 #1 ofcDNA was added to a reaction mixture containing 50 mM KC1, 10 mM Tris-HCl (pH 8.3), 3.0 mM MgCh, 0.01% gelatin, 0.2 mM deoxynucleoside triphosphates, 1 #M of each primer, and 2.5 U AmpliTaq polymer ase (Perkin-Elmer Corp., Hayward, CA). Each 100-#1 sample was overlayed with 75 #1 mineral oil (Sigma Chemical Co., St. Louis, MO) and incubated in a DNA thermal cycler (480; Perkin-Elmer Corp.) for a total of 40 cycles, each cycle consisting of 1 rain at 94~ 1 rain at 60~ (/~-actin and IFN-'y) or 67~ (IL-4), and 1 min at 72~ The amplified DNA size, as compared with a positive control (Clontech Laboratories), was 540 bp for 3-actin, 399 bp for IL-4, and 460 bp for IFN-% The PCR fragments were analyzed by 1.5% agarose gelelectrophoresis and visualized by ethidium bromide staining.
Results

Effect o/In Vivo Neutralization of lL4 on the Course of Inoculation Candidiasis.
In six independent experiments, CD2F1 mice received three weekly injections of anti-Ib4 (11Bll) or control antibodies starting 2 d before intravenous challenge with different numbers (5-50 x 104) of CA-6 blastospores. While aU control mice developed progressive, disseminated fatal candidiasis with median survival times of 5-18 d depending on challenge dose, the overall survival rate of anti-IL-4-treated mice (totalling 54) was 81%. The results of three representative experiments are summarized in Table 1 . In experiments not reported here, we also found that the beneficial effects of IL-4 depletion were essentiaUy lost when the size of the challenge inoculum was such (e.g., 106 cells or more) as to result in animals' death within the first 24-96 h of infection. However, once cured by anti-Ib4 treatment, survivor mice would consistently resist challenge with 106 CA-6 ceils as performed 12 wk after primary infection (Table 1) .
Quantitative cultures of kidneys and brains from control and anti-IL-4-treated mice were established 6 h and 1, 2, or 3 wk after injection of 7.5 x 104 CA-6 cells. Fig. 1 summarizes the results of one experiment representative of three, and shows that mAb treatment was associated with a dramatic reduction in fungal load in the organs of infected mice. At 3 wk, when no survivors were found in the control group (median survival time of 14.5 d), mice on anti-II~4 therapy had almost completely deared yeast cells from their organs. Examination of the kidneys from these mice provided histologic evidence of disease resolution (Fig. 2) . 
Effect of Anti-IL,4 Treatment on Footpad Reaction to the Yeast.
To assess the possible effect of anti-IL-4 treatment on development of DTH, mice challenged with 7.5 x 104 CA-6 cells, and treated with control or 11_811 antibodies, were injected intra-footpad with heat-inactivated blastospores 1, 2, or 3 wk after infection. The increase in footpad weight was measured 24 h later (Fig. 3 A) . Only mice receiving antiIb4 therapy and surviving CA-6 challenge developed significant footpad responses to the yeast. In addition, purified CD4 + lymphocytes from cured mice could adoptively transfer DTH reactivity to naive mice challenged intra-footpad with CA-6 cells 24 h after lymphocyte transfer (Fig. 3 B) . Upon systemic challenge with viable CA-6, enhanced dearance of the yeast from infected organs could be documented in the adoptively transferred mice (data not shown).
Effect of Anti-IL,4 Treatment on Serum Levels of Candida-specific
Antibodies. We next measured the levels of yeast-specific antibody levels in sera of mice infected with C. albicans and treated with control or 11B1 antibodies. At 1, 2, and 3 wk after injection of 7.5 x 104 CA-6 cells, sera were collected and assayed for their contents of total IgG, Ig2a, IgG1, and IgE. Fig. 4 shows that, in the 2 wk preceding their death, control mice exhibited higher IgG1 levels and lower IgG2a levels in comparison with Ib4-depleted animals. Significant levels of IgE were also found. However, anti-Ib4 treatment of infected mice resulted in complete suppression of IgE production.
Effect of Anti-Ib4 Treatment on Cytokine Production In
Vitro To assess the effect of Ib4 depletion on cytokine release in vitro by purified CD4 § lymphocytes from infected mice, mixed lymphocyte yeast cell cultures were established in the presence of accessory cells at 1, 2, and 3 wk after injection of 7.5 x 104 CA-6 cells. Appropriate controls included CD4 + cells from intact donors and yeast-primed CD4 + lymphocytes cultured with accessory cells but no fungal an- 
Expression of lIM and lFN-7 Genes in IL.4-depleted Mice.
To examine the patterns of cytokine gene transcription in Ib4-depleted mice, we extracted total RNA from CD4 + cells recovered at different times after infection, reverse transcribed the polyadenylated mRNA to obtain cDNA, and detected cDNA by PCR with IL-4-and IFN-'y-specific primers. PCR products were verified by probing samples transferred to a nylon membrane with a 32p-labeled internal oligonucleotide. To provide meaningful comparisons between control and IL-4-depleted mice, the cDNA samples were normalized to the ~/-actin PCR product, a marker for all cells. Fig. 6 shows the results obtained with RNA preparations from two independent experiments, each involving challenge of control and anti-Ib4-treated mice with 7.5 x 104 yeast cells, and harvest of CD4 + lymphocytes 3 and 10 d after infection. Although the PCR products were not quantitated, the results apparently indicate that decreased IL-4 mRNA levels were present in Ib4-depleted mice starting from 3 d postinfection, the decrease representing a manifold difference on day 10 (after the second mAb injection). A reciprocal increase in IFN-yspecific transcripts was apparently observed as a result of Ib4 depletion, with substantially higher levels of message on day 10.
Discussion
Although superficial and systemic mycoses in humans are associated with different predisposing conditions (20) , one feature common to all forms of candidiasis is that the intrinsic candidacidal activity of granulocytes and macrophages (the major effector cell types) is rather limited (1) , and that full expression of their function is contingent upon augmentation by cytokines released by antigen-specific and nonspecific cells (21, 22) . In addition, both specific and nonspecific modulation of immune responses have been reported as a consequence of C. albicans infection in mice. Garner et al. (23) showed that mannan administered intravenously to naive mice induced a population of suppressor T lymphocytes that, when transferred to immunized mice, suppressed antigen-specific DTH responses. Ashman (24) suggested that active downregulation of protective immunity might occur in mice that are genetically susceptible to candidiasis and are characterized by high antibody levels and poor DTH responses. Our laboratory has recently found that activation of Th2 cells occurs in mice infected with variants of the yeast that establish persistent colonization yet do not elicit protective immunity, and CD4 § cells from these mice were found to suppress Candida-specific DTH responses (11) .
In the present study we administered an anti-Ib4 mAb during the course of an otherwise lethal infection with the yeast. Provided the challenge inoculum did not result in shortterm mortality, a vast majority ('~80%) of the anti-Ib4-treated mice began to actively eliminate yeast cells from their organs, resolved their infections, and demonstrated Thl responses. In contrast, mice treated with control antibody experienced progressive, disseminated fatal candidiasis, and were characterized by weak or absent footpad responses, and higher IgG and IgE levels. The protective effect of anti-Ib4 treatment required the antibody to be given within approximately the first 2-3 d after infection, under which conditions a single antibody injection was almost as effective as the weekly administration regimen employed in this study (Romani et . Ib4 and IFN-y mRNA expression in CD4 + cells revealed by PCK normalized to fl-actin. RNA was isolated from lymphocytes of control (C) or 11Bll mAb-treated mice at 3 and 10 d after infection, and the resulting eDNA was used in the PCK with cytokine-specific primers. After amplification, 10/~1 of the reaction mix was removed, analyzed by 1.5% agarose gel electrophoresis, and visualized by ethidium bromide staining. The assay was performed with two different RNA preparations, and a second assay with the same RNA preparatiom gave analogous results. m, marker track (kilobase ladder consisting of pBR322 DNA cut with HaelII); N, no DNA added to the amplification mix during PCR.
fold differences with respect to control lymphocytes on day 10 postinfection.
In murine cutaneous leishmaniasis, the early and permanent conversion of nonhealer into healer mice induced by anti-I1-4 treatment (13, 25) , and the reversion of the effect by anti-IFN-3, (14) , indicates that the alteration of the disease outcome is primarily the consequence of changes in the basic nature of the T cell response, with a shift from a predominant Th2 to a Thl response. A similar mechanism of anti-I1.4 activity might apply to mouse infection with C. albicans, although in the present study we have not examined the role of T cell-derived IFN-3, in the efficacy of anti-I1.4 therapy. The striking difference in I1.4 mRNA observed at 10 d could indicate that I1.4 depletion leads to blockade of Th2 cell expansion. Because I1.4 is required for maturation of CD4 + precursors to the Th2 phenotype, neutralization of this factor would be expected to block both Th2 expansion and the subsequent formation of Th2-derived factors, such as I1.4 and I1. 10 , that limit protective Thl responses (14, 26) . In addition, the increase in IFN-y mRNA might indicate, and favor, the development of Thl reactivity, as IFN-y is crucially involved in the initial phases of Th responses in vivo (27) . Finally, neutralization of I1.-4 could further benefit the infected host by blocking the adverse effects of I1.4 on macrophage activation (28) and killing of phagocytosed yeast cells.
Elevated IgE, IgA, and IgG responses to the yeast show an inverse relationship with delayed skin responses in atopics (29) , in women suffering from recurrent Candida vaginitis (20, 30) , and in patients with chronic mucocutaneous candidiasis (20) . This suggests that humoral and cell-mediated immune responses to Candida in humans may be reciprocally regulated. Our present data that neutralization of endogenous I1.4 has therapeutic value in a murine model of systemic candidiasis could provide a means for improving our understanding of the host/parasite relationship, and also could offer the basis for attempting new strategies in the treatment of human candidiasis.
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